PLK1 and breast carcinoma: These data are reported for the first time and highlight the antitumor potential of calein C. Aurora kinases (A and B) and PLK-1 are overexpressed in some types of cancer, including breast cancer (Wolf et al., 2000; Weichert et al., 2005; Li and Li, 2006).